Return to Search
EN
When administering corticosteroid-containing injections, such as heel spur injection treatment, caution is required, especially in patients with diabetes and hypertension. Corticosteroids can affect blood sugar and blood pressure levels.
For diabetic patients:
If blood sugar levels are not well-controlled, it is critically important to consult an endocrinologist before injection therapy. Corticosteroids can cause an increase in blood sugar.
For hypertensive patients:
Corticosteroid use can lead to salt and fluid retention in the body, temporarily raising blood pressure. Therefore, blood pressure should be stable before starting treatment, and patients should be informed about a possible increase in blood pressure for several days.
In general, it is essential for the blood sugar and blood pressure levels of patients receiving injection therapy to be under control for treatment safety.
For patients using blood-thinning (anticoagulant) medication:
When invasive treatments such as injections or sound wave therapy are planned, the use of blood-thinning medications should be adjusted or temporarily discontinued a certain period in advance, with the evaluation and approval of a cardiology specialist, to minimize the risk of bleeding. Treatment should only be administered after medication adjustment has been made.
Can heel spur injection treatment be applied to chronic patients?
For diabetic patients:
If blood sugar levels are not well-controlled, it is critically important to consult an endocrinologist before injection therapy. Corticosteroids can cause an increase in blood sugar.
For hypertensive patients:
Corticosteroid use can lead to salt and fluid retention in the body, temporarily raising blood pressure. Therefore, blood pressure should be stable before starting treatment, and patients should be informed about a possible increase in blood pressure for several days.
In general, it is essential for the blood sugar and blood pressure levels of patients receiving injection therapy to be under control for treatment safety.
For patients using blood-thinning (anticoagulant) medication:
When invasive treatments such as injections or sound wave therapy are planned, the use of blood-thinning medications should be adjusted or temporarily discontinued a certain period in advance, with the evaluation and approval of a cardiology specialist, to minimize the risk of bleeding. Treatment should only be administered after medication adjustment has been made.